NASDAQ: AIDX
20/20 Biolabs Inc Stock Ownership - Who owns 20/20 Biolabs?

Insider buying vs selling

Have 20/20 Biolabs Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when AIDX insiders and whales buy or sell their stock.

AIDX Shareholders

What type of owners hold 20/20 Biolabs Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan M. Cohen9.77%1,366,400$247.32kInsider
John G. Compton0.10%14,335$2.59kInsider
John Woodson Rollins0.08%11,111$2.01kInsider
Richard M. Cohen0.06%7,700$1.39kInsider
Cresset Asset Management LLC0.00%240$43.44Institution
Citadel Advisors LLC0.00%63$11.40Institution
Geode Capital Management LLC0.00%54$9.77Institution
Vanguard Fiduciary Trust Co0.00%52$9.41Institution
Atlantic Union Bankshares Corp0.00%35$6.34Institution
Xtx Topco Ltd0.00%32$5.79Institution

1 of 3

AIDX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AIDX0.00%10.00%
IVF0.01%99.99%Net Selling
TNON0.00%100.00%Net SellingNet Selling
BJDX0.00%100.00%Net Buying
NUWE0.00%100.00%

20/20 Biolabs Stock Ownership FAQ

Who owns 20/20 Biolabs?

20/20 Biolabs (NASDAQ: AIDX) is owned by 0.00% institutional shareholders, 10.00% 20/20 Biolabs insiders, and 89.99% retail investors. Jonathan M. Cohen is the largest individual 20/20 Biolabs shareholder, owning 1.37M shares representing 9.77% of the company. Jonathan M. Cohen's 20/20 Biolabs shares are currently valued at $214.52k.

If you're new to stock investing, here's how to buy 20/20 Biolabs stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.